ERS Genomics
@ersgenomics
We enable access to the CRISPR/Cas9 intellectual property held by Nobel Prize-winner, Emmanuelle Charpentier. Talk to us about acquiring your license.
ID: 3226928939
https://www.ersgenomics.com/ 01-05-2015 20:43:53
735 Tweet
881 Takipçi
605 Takip Edilen
A recent article in Drug Target Review highlights three developments in the world of #geneediting. Three studies using #CRISPRCas9 include a new variant for #DNA repair, CRISPR-edited #CART cells to fight cancer, and mapping #genetic networks. Read more: bit.ly/3bHFIYL
